{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T10:16:24Z","timestamp":1758622584908},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neth Heart J"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1007\/s12471-012-0277-7","type":"journal-article","created":{"date-parts":[[2012,5,31]],"date-time":"2012-05-31T13:12:59Z","timestamp":1338469979000},"page":"279-287","source":"Crossref","is-referenced-by-count":8,"title":["Conflict of interest policies and disclosure requirements among European Society of Cardiology national cardiovascular journals"],"prefix":"10.1007","volume":"20","author":[{"name":"on behalf of the Editors\u2019 Network European Society of Cardiology Task Force","sequence":"first","affiliation":[]},{"given":"F.","family":"Alfonso","sequence":"first","affiliation":[]},{"given":"A.","family":"Timmis","sequence":"additional","affiliation":[]},{"given":"F. J.","family":"Pinto","sequence":"additional","affiliation":[]},{"given":"G.","family":"Ambrosio","sequence":"additional","affiliation":[]},{"given":"H.","family":"Ector","sequence":"additional","affiliation":[]},{"given":"P.","family":"Kulakowski","sequence":"additional","affiliation":[]},{"given":"P.","family":"Vardas","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2012,6,1]]},"reference":[{"key":"277_CR1","unstructured":"International Committee of Medical Journals Editors. Uniform Requirements for Manuscript Submitted to Biomedical Journals: Writing and Editing for Biomedical Publication. (Updated October 2008). Available: http:\/\/www.icmje.org\/ ."},{"key":"277_CR2","unstructured":"Council of Science Editors. CSE\u2019s White Paper on Promoting Integrity in Scientific Journal Publications. Editorial policy committee (2005\u20132006). Available: http:\/\/www.CouncilScienceEditors.org"},{"key":"277_CR3","unstructured":"World Association of Medical Editors. WAME recommendations on Publication Ethics and Policies for Medical Journals. Available: http:\/\/www.wame.org\/resources\/ethics-resources ."},{"key":"277_CR4","unstructured":"Committee On Publication Ethics. COPE. Code of Conduct and Best Practice Guidelines for Journal Editors. Available: http:\/\/publicationethics.org\/resources\/guidelines ."},{"issue":"6","key":"277_CR5","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1157\/13062928","volume":"57","author":"F Alfonso","year":"2004","unstructured":"Alfonso F, Bermejo J, Segovia J. New recommendations of the international committee of medical journal editors. Shifting focus: from uniformity in technical requirements to bioethical considerations. Rev Esp Cardiol. 2004;57(6):592\u20133.","journal-title":"Rev Esp Cardiol."},{"issue":"20","key":"277_CR6","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1001\/jama.2009.1669","volume":"302","author":"JA Blum","year":"2009","unstructured":"Blum JA, Freeman K, Dart RC, et al. Requirements and definitions in conflict of interest policies of medical journals. JAMA. 2009;302(20):2230\u20134.","journal-title":"JAMA"},{"issue":"12","key":"277_CR7","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1111\/j.1525-1497.2006.00598.x","volume":"21","author":"RJ Cooper","year":"2006","unstructured":"Cooper RJ, Gupta M, Wilkes MS, et al. Conflict of interest disclosure policies and practices in peer-reviewed biomedical journals. J Gen Intern Med. 2006;21(12):1248\u201352.","journal-title":"J Gen Intern Med"},{"issue":"4","key":"277_CR8","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1001\/jama.289.4.454","volume":"289","author":"JE Bekelman","year":"2003","unstructured":"Bekelman JE, MPhil YL, Gross CP. Scope and impact of financial conflicts of interest in biomedical research: a systematic review. JAMA. 2003;289(4):454\u201365.","journal-title":"JAMA"},{"issue":"2","key":"277_CR9","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1001\/jama.302.2.198","volume":"302","author":"CD DeAngelis","year":"2009","unstructured":"DeAngelis CD, Fontanarosa PB. Resolving unreported conflicts of interest. JAMA. 2009;302(2):198\u20139.","journal-title":"JAMA"},{"key":"277_CR10","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1056\/NEJMlim042229","volume":"351","author":"DM Studdert","year":"2004","unstructured":"Studdert DM, Mello MM, Phil M, et al. Financial conflicts of interest in physicians\u00b4 relationships with the pharmaceutical industry. Self-regulation in the shadow of federal prosecution. N Engl J Med. 2004;351:1891\u2013900.","journal-title":"N Engl J Med"},{"issue":"19","key":"277_CR11","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1056\/NEJMe0909052","volume":"361","author":"JM Drazen","year":"2009","unstructured":"Drazen JM, Van der Weyden MB, Sahni P, et al. Uniform format for disclosure of competing interests in ICMJE journals. N Engl J Med. 2009;361(19):1896\u20137.","journal-title":"N Engl J Med"},{"issue":"2","key":"277_CR12","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1056\/NEJMe1006030","volume":"363","author":"JM Drazen","year":"2010","unstructured":"Drazen JM, de Leeuw PW, Laine C, et al. Toward more uniform conflict disclosures - The updated ICMJE conflict of interest reporting form. N Engl J Med. 2010;363(2):188\u20139.","journal-title":"N Engl J Med"},{"issue":"6","key":"277_CR13","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1157\/13123071","volume":"61","author":"F Alfonso","year":"2008","unstructured":"Alfonso F, Ambrosio G, Pinto FJ, et al. European National Society cardiovascular journals. Background, rationale and mission statement of the \u201cEditors\u2019 Club\u201d. Rev Esp Cardiol. 2008;61(6):644\u201350.","journal-title":"Rev Esp Cardiol."},{"issue":"1","key":"277_CR14","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1093\/eurheartj\/ehp462","volume":"31","author":"F Alfonso","year":"2010","unstructured":"Alfonso F, Ambrosio G, Pinto FJ, et al. Editors\u2019 Network ESC Task Force. European Society of Cardiology national cardiovascular journals: the \u2018Editors\u2019 Network\u2019. Eur Heart J. 2010;31(1):26\u20138.","journal-title":"Eur Heart J"},{"issue":"24","key":"277_CR15","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1136\/hrt.2009.186338","volume":"95","author":"P Mills","year":"2009","unstructured":"Mills P, Timmis A, Huber K, et al. The role of European national journals in education. Heart. 2009;95(24):e3.","journal-title":"Heart."},{"issue":"8","key":"277_CR16","first-page":"919","volume":"32","author":"F Alfonso","year":"2011","unstructured":"Alfonso F. The Editors\u2019 Network of the European Society of Cardiology. Eur Heart J. 2011;32(8):919\u201321.","journal-title":"Eur Heart J"},{"issue":"17","key":"277_CR17","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1056\/NEJMe0802618","volume":"358","author":"RS Schwartz","year":"2008","unstructured":"Schwartz RS, Curfman GD, Morrissey S, et al. Full disclosure and the funding of biomedical research. N Engl J Med. 2008;358(17):1850\u20131.","journal-title":"N Engl J Med"},{"key":"277_CR18","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/S1470-2045(09)70244-X","volume":"10","author":"J Simone","year":"2009","unstructured":"Simone J. More interest in conflicts of interest. Lancet Oncol. 2009;10:836\u20137.","journal-title":"Lancet Oncol"},{"key":"277_CR19","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1002\/clc.20738","volume":"32","author":"RC Conti","year":"2009","unstructured":"Conti RC. Conflict of interest. Clin Cardiol. 2009;32:666\u20137.","journal-title":"Clin Cardiol"},{"issue":"1","key":"277_CR20","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1001\/jama.294.1.110","volume":"294","author":"PB Fontanarosa","year":"2005","unstructured":"Fontanarosa PB, Flanagin A, DeAngelis CD. Reporting conflicts of interest, financial aspects of research and role of sponsors in funded studies. JAMA. 2005;294(1):110\u20131.","journal-title":"JAMA"},{"issue":"2","key":"277_CR21","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.amjmed.2004.12.003","volume":"118","author":"JS Alpert","year":"2005","unstructured":"Alpert JS. Doctors and the drug industry: how can we handle potential conflicts of interest? Am J Med. 2005;118(2):99\u2013100.","journal-title":"Am J Med"},{"issue":"4","key":"277_CR22","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.amjmed.2008.01.010","volume":"121","author":"JS Alpert","year":"2008","unstructured":"Alpert JS. Doctors and the drug-industry: further thoughts for dealing with potential conflicts of interest? Am J Med. 2008;121(4):253\u20135.","journal-title":"Am J Med"},{"issue":"9","key":"277_CR23","doi-asserted-by":"crossref","first-page":"771","DOI":"10.4065\/84.9.771","volume":"84","author":"WL Lanier","year":"2009","unstructured":"Lanier WL. Bidirectional conflicts of interest involving industry and medical journals: who will champion integrity? Mayo Clin Proc. 2009;84(9):771\u20135.","journal-title":"Mayo Clin Proc."},{"issue":"2","key":"277_CR24","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jacc.2009.06.001","volume":"54","author":"A Bove","year":"2009","unstructured":"Bove A. Relations with industry: thoughts on claims of a broken system. J Am Coll Cardiol. 2009;54(2):177\u20139.","journal-title":"J Am Coll Cardiol"},{"issue":"20","key":"277_CR25","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1056\/NEJM200005183422024","volume":"342","author":"T Bodenheimer","year":"2000","unstructured":"Bodenheimer T. The uneasy alliance: clinical investigators and the pharmaceutical industry. N Engl J Med. 2000;342(20):1539\u201344.","journal-title":"N Engl J Med"},{"key":"277_CR26","doi-asserted-by":"crossref","first-page":"b4949","DOI":"10.1136\/bmj.b4949","volume":"339","author":"B Goldacre","year":"2009","unstructured":"Goldacre B. Is the conflict of interest unacceptable when drug companies conduct trials on their own drugs? Yes. BMJ. 2009;339:b4949.","journal-title":"BMJ."},{"key":"277_CR27","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/S0140-6736(01)06035-4","volume":"358","author":"F Davidoff","year":"2001","unstructured":"Davidoff F, de Angelis CD, Drazen JM, et al. International Committee of Medical Journal Editors. Sponsorship, authorship and accountability. Lancet. 2001;358:854\u20136.","journal-title":"Lancet."},{"issue":"6","key":"277_CR28","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1001\/jama.289.6.741","volume":"289","author":"MM Johns","year":"2003","unstructured":"Johns MM, Barners M, Florencio PS. Restoring balance to industry-academia relationships in an era of institutional financial conflicts of interest: promoting research while maintaining trust. JAMA. 2003;289(6):741\u20136.","journal-title":"JAMA."},{"issue":"11","key":"277_CR29","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1157\/13095794","volume":"59","author":"F Alfonso","year":"2006","unstructured":"Alfonso F, Segovia J, Heras M, et al. Publication of clinical trials in scientific journals: Editorial issues. Rev Esp Cardiol. 2006;59(11):1206\u201314.","journal-title":"Rev Esp Cardiol."},{"issue":"7549","key":"277_CR30","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1136\/bmj.38768.420139.80","volume":"332","author":"NA Patsopoulos","year":"2006","unstructured":"Patsopoulos NA, Analatos AA, Ioannidis JP. Origin and funding of the most frequently cited papers in medicine: database analysis. BMJ. 2006;332(7549):1061\u20134.","journal-title":"BMJ."},{"issue":"7400","key":"277_CR31","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1136\/bmj.326.7400.1167","volume":"326","author":"J Lexchin","year":"2003","unstructured":"Lexchin J, Bero LA, Djulbegovic B, et al. Pharmaceutical industry sponsorship and research outcome and quality: systematic review. BMJ. 2003;326(7400):1167\u201370.","journal-title":"BMJ."},{"issue":"11","key":"277_CR32","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.amjmed.2004.05.029","volume":"117","author":"TE Finucane","year":"2004","unstructured":"Finucane TE, Boult CE. Association of funding and findings of pharmaceutical research at a meeting of a medical professional society. Am J Med. 2004;117(11):842\u20135.","journal-title":"Am J Med."},{"issue":"9","key":"277_CR33","doi-asserted-by":"crossref","first-page":"811","DOI":"10.4065\/84.9.811","volume":"84","author":"LJ Hirsch","year":"2009","unstructured":"Hirsch LJ. Conflicts of interest, authorship, and disclosures in industry-related scientific publications: The tort bar and editorial oversight of medical journals. Mayo Clin Proc. 2009;84(9):811\u201321.","journal-title":"Mayo Clin Proc"},{"issue":"4","key":"277_CR34","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1001\/jama.290.4.495","volume":"290","author":"MK Krzyanowska","year":"2003","unstructured":"Krzyanowska MK, Pintilie M, Tannock IF. Factors associated with failure to publish large randomized trials presented at an oncology meeting. JAMA. 2003;290(4):495\u2013501.","journal-title":"JAMA"},{"issue":"7","key":"277_CR35","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1503\/cmaj.1041086","volume":"171","author":"AW Chan","year":"2004","unstructured":"Chan AW, Krleza-Jeri\u0107 K, Schmid I, et al. Outcome reporting bias in randomized trials funded by the Canadian Institutes of Health Research. CMAJ. 2004;171(7):735\u201340.","journal-title":"CMAJ."},{"issue":"5","key":"277_CR36","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1157\/13074852","volume":"58","author":"F Alfonso","year":"2005","unstructured":"Alfonso F, Bermejo J, Segovia J. Duplicate or redundant publication: can we afford it? Rev Esp Cardiol. 2005;58(5):601\u20134.","journal-title":"Rev Esp Cardiol."},{"issue":"4","key":"277_CR37","first-page":"481","volume":"170","author":"L Hirsch","year":"2004","unstructured":"Hirsch L. Randomized clinical trials: what gets published, and when? CMAJ. 2004;170(4):481\u20133.","journal-title":"CMAJ."},{"issue":"7358","key":"277_CR38","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1136\/bmj.325.7358.249","volume":"325","author":"LL Kjaergard","year":"2002","unstructured":"Kjaergard LL, Als-Nielsen B. Association between competing interests and authors' conclusions: epidemiological study of randomised clinical trials published in the BMJ. BMJ. 2002;325(7358):249.","journal-title":"BMJ."},{"issue":"19","key":"277_CR39","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1001\/jama.295.19.2270","volume":"295","author":"PM Ridker","year":"2006","unstructured":"Ridker PM, Torres J. Reported outcomes in major cardiovascular clinical trials funded by for profit and not-for-profit organizations: 2000\u20132005. JAMA. 2006;295(19):2270\u20134.","journal-title":"JAMA."},{"issue":"2","key":"277_CR40","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s11948-001-0041-7","volume":"7","author":"S Krimsky","year":"2001","unstructured":"Krimsky S, Rothenberg LS. Conflict of interest policies in science and medical journals: editors practices and authors disclosures. Sci Eng Ethics. 2001;7(2):205\u201318.","journal-title":"Sci Eng Ethics"},{"issue":"2","key":"277_CR41","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s11948-007-9011-z","volume":"13","author":"JS Ancker","year":"2007","unstructured":"Ancker JS, Flanagin A. A comparison of conflict of interest policies at peer-reviewed journals in different scientific disciplines. Sci Eng Ethics. 2007;13(2):147\u201357.","journal-title":"Sci Eng Ethics"},{"issue":"5","key":"277_CR42","doi-asserted-by":"crossref","first-page":"e2128","DOI":"10.1371\/journal.pone.0002128","volume":"3","author":"KP Weinfurt","year":"2008","unstructured":"Weinfurt KP, Seils DM, Tzeng JP, et al. Consistency of financial interest disclosures in the biomedical literature: The case of coronary stents. PLoS ONE. 2008;3(5):e2128.","journal-title":"PLoS ONE"},{"issue":"5","key":"277_CR43","doi-asserted-by":"crossref","first-page":"e138","DOI":"10.1371\/journal.pmed.0020138","volume":"2","author":"R Smith","year":"2005","unstructured":"Smith R. Medical journals are an extension of the marketing arm of pharmaceutical companies. PLoS Med. 2005;2(5):e138.","journal-title":"PLoS Med"},{"issue":"1","key":"277_CR44","doi-asserted-by":"crossref","first-page":"73","DOI":"10.7326\/0003-4819-141-1-200407060-00020","volume":"141","author":"T Editors","year":"2004","unstructured":"Editors T. Publishing commentary by authors with potential conflicts of interest: When, Why and How. Annals Intern Med. 2004;141(1):73\u20134.","journal-title":"Annals Intern Med"},{"issue":"19","key":"277_CR45","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1016\/j.jacc.2008.01.044","volume":"51","author":"G Vorobiof","year":"2008","unstructured":"Vorobiof G. Do conflict of interest really matter or does no one read the fine print anyway? J Am Coll Cardiol. 2008;51(19):1911.","journal-title":"J Am Coll Cardiol"},{"key":"277_CR46","doi-asserted-by":"crossref","first-page":"b3139","DOI":"10.1136\/bmj.b3139","volume":"339","author":"JH Tanne","year":"2009","unstructured":"Tanne JH. US Senate committee investigates conflicts of interest in industry funded medical education. BMJ. 2009;339:b3139.","journal-title":"BMJ."},{"issue":"21","key":"277_CR47","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1001\/jama.1993.03500210082037","volume":"269","author":"KJ Rothman","year":"1993","unstructured":"Rothman KJ. Conflict of interest. The new McCarthyism in science. JAMA. 1993;269(21):2782\u20134.","journal-title":"JAMA"},{"issue":"5","key":"277_CR48","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.recesp.2011.02.006","volume":"64","author":"P Avanzas","year":"2011","unstructured":"Avanzas P, Bayes-Genis A, P\u00e9rez de Isla L, et al. Ethical considerations in the publication of scientific articles. Rev Esp Cardiol. 2011;64(5):427\u20139.","journal-title":"Rev Esp Cardiol."},{"key":"277_CR49","doi-asserted-by":"crossref","unstructured":"Relations between professional medical associations and the health-care industry, concerning scientific communication and continuing medical education: a Policy Statement from the European Society of Cardiology Eur Heart J. 2012 March; 33(5): 666\u2013674","DOI":"10.1093\/eurheartj\/ehr480"}],"container-title":["Netherlands Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12471-012-0277-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12471-012-0277-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12471-012-0277-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,29]],"date-time":"2019-06-29T08:10:56Z","timestamp":1561795856000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12471-012-0277-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":49,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["277"],"URL":"https:\/\/doi.org\/10.1007\/s12471-012-0277-7","relation":{},"ISSN":["1568-5888","1876-6250"],"issn-type":[{"type":"print","value":"1568-5888"},{"type":"electronic","value":"1876-6250"}],"subject":[],"published":{"date-parts":[[2012,6]]}}}